High-throughput analysis of the impact of antibiotics on the human intestinal microbiota composition

Journal of Microbiological Methods

Volumn 92, Issue 3, 2013, Pages 387-397

  Ladirat, S E ^a   Schols, H A ^a   Nauta, A ^b   Schoterman, M H C ^b   Keijser, B J F ^c   Montijn, R C ^c   Gruppen, H ^a   Schuren, F H J ^c  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b FRIESLANDCAMPINA   (Netherlands)

^c TNO   (Netherlands)

Author keywords

Antibiotics; In vitro fermentation screening platform; Intestinal microbiota; Phylogenetic microarray

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFADROXIL; CIPROFLOXACIN; CLINDAMYCIN; COMPLEMENTARY DNA; DOXYCYCLINE; ERYTHROMYCIN; PENICILLIN DERIVATIVE;

ANTIBIOTIC THERAPY; ARTICLE; BACTEROIDES; BACTEROIDES FRAGILIS; BACTEROIDES UNIFORMIS; BIFIDOBACTERIUM; CELL COUNT; CLOSTRIDIUM; CONTROLLED STUDY; DNA ISOLATION; DNA MICROARRAY; DNA SYNTHESIS; DOSE RESPONSE; DRUG ABSORPTION; ENTEROBACTERIACEAE; FERMENTATION SCREENING PLATFORM; FERMENTATION TECHNIQUE; HIGH THROUGHPUT SCREENING; HUMAN; IN VITRO STUDY; INTESTINE FLORA; LACTOBACILLUS; LACTOBACILLUS BREVIS; LACTOBACILLUS GASSERI; MICROARRAY ANALYSIS; MICROBIAL COMMUNITY; MINIMUM INHIBITORY CONCENTRATION; PEPTIDE SYNTHESIS; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA ISOLATION; TRANSLATION INITIATION;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIOLOGICAL TECHNIQUES; BIOTA; FECES; FEMALE; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MALE; METAGENOME; MICROARRAY ANALYSIS; MIDDLE AGED; MODELS, THEORETICAL; PHYLOGENY;

EID: 84874573089     PISSN: 01677012     EISSN: 18728359     Source Type: Journal    
DOI: 10.1016/j.mimet.2012.12.011     Document Type: Article

References (34)

1. Bartlett J.G. Antibiotic-associated diarrhea. N. Engl. J. Med. 2002, 346:334-339.
2. Bartosch S., Fite A., Macfarlane G.T., McMurdo M.E.T. Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl. Environ. Microbiol. 2004, 70:3575-3581.
3. Brötz-Oesterhelt H., Brunner N.A. How many modes of action should an antibiotic have?. Curr. Opin. Pharmacol. 2008, 8:564-573.
4. Carroll I.M., Andrus J.M., Bruno-Bárcena J.M., Klaenhammer T.R., Hassan H.M., Threadgill D.S. Anti-inflammatory properties of Lactobacillus gasseri expressing manganese superoxide dismutase using the interleukin 10-deficient mouse model of colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 293:G729-G738.
5. Crielaard W., Zaura E., Schuller A.A., Huse S.M., Montijn R.C., Keijser B.J.F. Exploring the oral microbiota of children at various developmental stages of their dentition in the relation to their oral health. BMC Med. Genomics 2011, 4.
6. De La Cochetière M.F., Durand T., Lepage P., Bourreille A., Galmiche J.P., Doré J. Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge. J. Clin. Microbiol. 2005, 43:5588-5592.
7. De La Cochetière M.F., Montassier E., Hardouin J.B., Carton T., Le Vacon F., Durand T., Lalande V., Petit J.C., Potel G., Beaugerie L. Human intestinal microbiota gene risk factors for antibiotic-associated diarrhea: perspectives for prevention. Microb. Ecol. 2010, 59:830-837.
8. Donskey C.J., Hujer A.M., Das S.M., Pultz N.J., Bonomo R.A., Rice L.B. Use of denaturing gradient gel electrophoresis for analysis of the stool microbiota of hospitalized patients. J. Microbiol. Methods 2003, 54:249-256.
9. Drew R.H., Gallis H.A. Azithromycin-spectrum of activity, pharmacokinetics, and clinical applications. Pharmacotherapy 1992, 12:161-173.
10. ESAC- Yearbook http://www.esac.ua.ac.be/main.aspx?c=*ESAC2&n=50036.
11. EUCAST breakpoints http://www.eucast.org/eucast_disk_diffusion_test/breakpoints/.
12. Guarner F., Malagelada J.R. Gut flora in health and disease. Lancet 2003, 361:512-519.
13. Gullberg E., Cao S., Berg O.G., Ilbäck C., Sandegren L., Hughes D., Andersson D.I. Selection of resistant bacteria at very low antibiotic concentrations. PLoS Pathog. 2011, 7.
14. Jernberg C., Sullivan Ã., Edlund C., Jansson J.K. Monitoring of antibiotic-induced alterations in the human intestinal microflora and detection of probiotic strains by use of terminal restriction fragment length polymorphism. Appl. Environ. Microbiol. 2005, 71:501-506.
15. Kang S., Denman S.E., Morrison M., Yu Z., Dore J., Leclerc M., McSweeney C.S. Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray. Inflamm. Bowel Dis. 2010, 16:2034-2042.
16. Klappenbach J.A., Saxman P.R., Cole J.R., Schmidt T.M. Rrndb: the ribosomal RNA operon copy number database. Nucleic Acids Res. 2001, 29:181-184.
17. Kobayashi H., Oethinger M., Tuohy M.J., Hall G.S., Bauer T.W. Distinction between intact and antibiotic-inactivated bacteria by real-time PCR after treatment with propidium monoazide. J. Orthop. Res. 2010, 28:1245-1251.
18. Kort R., Keijser B.J., Caspers M.P.M., Schuren F.H., Montijn R. Transcriptional activity around bacterial cell death reveals molecular biomarkers for cell viability. BMC Genomics 2008, 9.
19. Mangin I., Suau A., Gotteland M., Brunser O., Pochart P. Amoxicillin treatment modifies the composition of Bifidobacterium species in infant intestinal microbiota. Anaerobe 2010, 16:433-438.
20. McFarland L.V. Antibiotic-associated diarrhea: epidemiology, trends and treatment. Future Microbiol. 2008, 3:563-578.
21. Minekus M., Smeets-Peeters M., Havenaar R., Bernalier A., Fonty G., Marol-Bonnin S., Alric M., Marteau P., Huis In't Veld J.H.J. A computer-controlled system to simulate conditions of the large intestine with peristaltic mixing, water absorption and absorption of fermentation products. Appl. Microbiol. Biotechnol. 1999, 53:108-114.
22. NETHMAP http://http://www.swab.nl/swab/cms3.nsf/uploads/D61A8F6E60555F3%20C125763900414B7B/$FILE/nethmap2009_21-9-2009.pdf.
23. Nocker A., Mazza A., Masson L., Camper A.K., Brousseau R. Selective detection of live bacteria combining propidium monoazide sample treatment with microarray technology. J. Microbiol. Methods 2009, 76:253-261.
24. Rafii F., Sutherland J.B., Cerniglia C.E. Effects of treatment with antimicrobial agents on the human colonic microflora. Ther. Clin. Risk Manag. 2008, 4:1343-1357.
25. Rajilić-Stojanović M., Heilig H.G.H.J., Molenaar D., Kajander K., Surakka A., Smidt H., De Vos W.M. Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environ. Microbiol. 2009, 11:1736-1751.
26. Saarela M., Maukonen J., von Wright A., Vilpponen-Salmela T., Patterson A.J., Scott K.P., Hämynen H., Mättö J. Tetracycline susceptibility of the ingested Lactobacillus acidophilus LaCH-5 and Bifidobacterium animalis subsp. lactis Bb-12 strains during antibiotic/probiotic intervention. Int. J. Antimicrob. Agents 2007, 29:271-280.
27. Saeed A.I., Sharov V., White J., Li J., Liang W., Bhagabati N., Braisted J., Klapa M., Currier T., Thiagarajan M., Sturn A., Snuffin M., Rezantsev A., Popov D., Ryltsov A., Kostukovich E., Borisovsky I., Liu Z., Vinsavich A., Trush V., Quackenbush J. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003, 34:374-378.
28. Sullivan A. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect. Dis. 2001, 1:101-114.
29. Weil J., Miramonti J., Ladisch M.R. Cephalosporin C: mode of action and biosynthetic pathway. Enzyme Microb. Technol. 1995, 17:85-87.
30. Woodmansey E.J. Intestinal bacteria and ageing. J. Appl. Microbiol. 2007, 102:1178-1186.
31. Yap I.K.S., Li J.V., Saric J., Martin F.P., Davies H., Wang Y., Wilson I.D., Nicholson J.K., Utzinger J., Marchesi J.R., Holmes E. Metabonomic and microbiological analysis of the dynamic effect of vancomycin-lnduced gut microbiota modification in the mouse. J. Proteome Res. 2008, 7:3718-3728.
32. Zoetendal E.G., Akkermans A.D.L., De Vos W.M. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl. Environ. Microbiol. 1998, 64:3854-3859.
33. Zoetendal E.G., Vaughan E.E., De Vos W.M. A microbial world within us. Mol. Microbiol. 2006, 59:1639-1650.
34. Zoetendal E.G., Rajilić-Stojanović M., De Vos W.M. High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 2008, 57:1605-1615.